| Zim Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541400 |
NSE Symbol : ZIMLAB |
P/E(TTM) : 139.94 |
|
ISIN Demat : INE518E01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.82 |
|
Book Value(₹) : 52.94 |
Market Cap(₹Cr) : 615.73 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 93.05 | 102.85 | 107.81 | 88.39 | 71.43 | 108.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 93.05 | 102.85 | 107.81 | 88.39 | 71.43 | 108.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.99 | 6.16 | 1.71 | 2.04 | 1.48 | 1.55 |
| Total Income | 94.03 | 109.01 | 109.52 | 90.44 | 72.90 | 110.07 |
| Total Expenditure | 90.64 | 96.28 | 95.31 | 82.22 | 67.09 | 93.28 |
| PBIDT | 3.39 | 12.74 | 14.21 | 8.22 | 5.81 | 16.79 |
| Interest | 3.64 | 3.31 | 3.43 | 3.16 | 3.30 | 2.91 |
| PBDT | -0.25 | 9.43 | 10.78 | 5.06 | 2.51 | 13.88 |
| Depreciation | 5.17 | 4.90 | 4.85 | 4.83 | 4.79 | 5.23 |
| Tax | 0.00 | 1.81 | 1.47 | 0.00 | 0.00 | 3.34 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.55 | -0.57 | 0.20 | 0.11 | -0.59 | -0.11 |
| Reported Profit After Tax | -3.88 | 3.28 | 4.26 | 0.12 | -1.69 | 5.42 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -3.88 | 3.28 | 4.26 | 0.12 | -1.69 | 5.42 |
| EPS (Unit Curr.) | -0.72 | 0.67 | 0.87 | 0.03 | -0.35 | 1.11 |
| EPS (Adj) (Unit Curr.) | -0.72 | 0.67 | 0.87 | 0.03 | -0.35 | 1.11 |
| Calculated EPS (Unit Curr.) | -0.72 | 0.61 | 0.87 | 0.02 | -0.35 | 1.11 |
| Calculated EPS (Adj) (Unit Curr.) | -0.72 | 0.61 | 0.87 | 0.02 | -0.35 | 1.11 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.89 | 2.45 | 3.50 | 0.10 | -1.39 | 4.45 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.89 | 2.45 | 3.50 | 0.10 | -1.39 | 4.45 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 53.55 | 53.50 | 48.74 | 48.74 | 48.73 | 48.73 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.64 | 12.39 | 13.18 | 9.30 | 8.13 | 15.47 |
| PBDTM(%) | -0.27 | 9.17 | 10.00 | 5.72 | 3.51 | 12.79 |
| PATM(%) | -4.17 | 3.19 | 3.95 | 0.14 | -2.37 | 4.99 |
